May 13, 2026 01:00AM
Mar 26, 2026 02:00AM
Nov 13, 2025 01:00AM
Nov 10, 2025 01:01AM
Nov 10, 2025 01:00AM
Oct 23, 2025 07:10AM
Oct 14, 2025 01:00AM Innate Pharma to Host Analyst and Investor Event on Lacutamab on October 28, 2025
Sep 17, 2025 01:00AM
May 23, 2025 01:00AM
May 13, 2025 01:00AM
Apr 16, 2025 01:00AM
Mar 27, 2025 02:00AM
Feb 17, 2025 01:02AM
Jan 21, 2025 01:00AM Innate Pharma Announces Nectin-4 Antibody Drug Conjugate Investor and Analyst Event in New York
Dec 9, 2024 01:00AM
Dec 3, 2024 01:00AM
Nov 13, 2024 01:00AM
Sep 23, 2024 01:00AM
Sep 12, 2024 01:00AM
Jun 17, 2024 01:00AM
Jun 4, 2024 01:00AM Innate Pharma Presents Positive Results From TELLOMAK Phase 2 Study With Lacutamab in Mycosis Fungoides
May 21, 2024 01:00AM
May 14, 2024 01:00AM
Apr 15, 2024 01:00AM
Mar 21, 2024 02:00AM
Jan 4, 2024 05:10AM
Jan 4, 2024 01:00AM
Dec 11, 2023 03:43AM Innate Pharma (IPH) Reports Efficacy and Safety Phase 1 /2 Results of NK Cell Engager SAR443579 / IPH6101
Dec 11, 2023 01:00AM
Dec 10, 2023 01:00AM
Nov 27, 2023 01:00AM
Nov 14, 2023 01:00AM
Oct 5, 2023 04:48AM
Oct 5, 2023 01:00AM
Sep 22, 2023 01:00AM Innate Pharma Announces Encore Presentation of Interim Results of Phase 2 TELLOMAK Study With Lacutamab With Updated Olsen 2022 Criteria at the EORTC Cutaneous Lymphoma Tumour Group Annual Meeting 202
Sep 14, 2023 01:00AM
Jun 16, 2023 06:05AM
Jun 16, 2023 01:00AM
Jun 12, 2023 01:00AM
Jun 8, 2023 01:00AM
Jun 8, 2023 01:00AM
Dec 10, 2022 10:00AM Innate Pharma Presents Data From Ongoing Phase 2 TELLOMAK Trial Demonstrating Clinical Activity of Lacutamab in Advanced Sézary Syndrome at ASH 2022
Nov 4, 2022 02:00AM
Mar 18, 2021 02:00AM
Dec 11, 2020 01:00AM
Dec 3, 2020 08:30AM
Dec 2, 2020 01:00AM
Nov 24, 2020 05:00PM
Nov 17, 2020 01:00AM Innate Pharma Reports Third Quarter 2020 Financial Results and Business Update
Nov 13, 2020 01:00AM

323,630 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All